Results: 76

Functional performance and muscular strength in symptomatic female carriers of Duchenne muscular dystrophy

Arq. neuropsiquiatr; 78 (3), 2020
Abstract Duchenne muscular dystrophy (DMD) usually affects men. However, women are also affected in rare instances. Approximately 8% of female DMD carriers have muscle weakness and cardiomyopathy. The early identification of functional and motor impairments can support clinical decision making. Objectiv...

Fisioterapia aquática em indivíduos com distrofia muscular: uma revisão sistemática do tipo escopo

RESUMO O objetivo deste estudo foi mapear o uso da fisioterapia aquática em indivíduos com distrofias musculares, de forma a caracterizar as intervenções no meio aquático e identificar componentes mensurados (variáveis estudadas e instrumentos utilizados nos estudos). A revisão sistemática do tip...

Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy

Biol. Res; 53 (), 2020
BACKGROUND: Duchenne muscular dystrophy (DMD) is a devastating genetic muscular disorder with no effective treatment that is caused by the loss of dystrophin. Human induced pluripotent stem cells (hiPSCs) offer a promising unlimited resource for cell-based therapies of muscular dystrophy. However, their ...

Prevalencia de dolor crónico en pacientes con distrofia muscular de Duchenne en etapas no ambulantes

INTRODUCTION: Chronic pain is a frequent symptom in patients with Duchenne muscular dystrophy (DMD) as reported, in up to 73%, affecting their normal activities, participation and quality of life; however it is an underdiagnosed symptom, and therefore, undertreated. OBJECTIVE: to establish the prevalence...

The association of hand grip strength with functional measures in non-ambulatory children with Duchenne muscular dystrophy

Arq. neuropsiquiatr; 77 (11), 2019
ABSTRACT Duchenne muscular dystrophy (DMD) is a disease characterized by progressive loss of muscle fiber, gradually from proximal to distal. Although a few studies have investigated hand grip strength in non-ambulatory DMD patients, a lack of literature was found determining its relationship with functi...

Avances en el tratamiento de la distrofia de Duchenne
Advances in the treatment of Duchenne muscular dystrophy

Medicina (B.Aires); 79 (supl.3), 2019
La distrofia muscular de Duchenne es una enfermedad genéticamente determinada, ligada al cromosoma X y caracterizada clínicamente por producir debilidad muscular progresiva, con una incidencia de 1 por cada 3500-6000 varones nacidos. Es causada por la mutaciones en el gen DMD, el cual codifica la distr...

Duchenne muscular dystrophy: an historical treatment review

Arq. neuropsiquiatr; 77 (8), 2019
ABSTRACT In this review, we discuss the therapies used in the treatment of patients with Duchenne muscular dystrophy since the first description of the disease. A short description is given of the various theories based on disease pathogenesis, which give the substrates for the many therapeutic intervent...

Guillaume-Benjamin Duchenne: a miserable life dedicated to science

Arq. neuropsiquiatr; 77 (6), 2019
ABSTRACT Duchenne de Boulogne is known mainly by the disease eponymously named "Duchenne muscular dystrophy", or pseudohypertrophic muscular dystrophy, although some experts consider that the original description of this disease does not belong to him. Less well known are the facts related to the tragic ...

First psychotic episode in an adult with Becker muscular dystrophy

Distrofia muscular de Becker con duplicación en el exón 5 del gen DMD

Repert. med. cir; 28 (2), 2019
Las distrofinopatías son un grupo de enfermedades ligadas al cromosoma X que abarcan diferentes entidades, siendo las más importantes la distrofia muscular de Duchenne (DMD) y la de Becker (DMB). Están causadas por mutaciones en el gen de la distrofina (gen DMD) localizado en el ...